DNA circle formation in Neisseria gonorrhoeae: a possible intermediate in diverse genomic recombination processes.
An important attribute that contributes to the virulence of Neisseria gonorrhoeae is its phenotypic variability, which is based on recombination within complex gene families in the genome. In this study we report on the in vivo amplification of large segments of the genome and the existence of circular DNA intermediates in the cell, which might help to explain the evolution of these gene families and provide possible clues as to how genetic variability is maintained. Using an inserted chromosomal marker (cat) in the N. gonorrhoeae MS11 genome that confers low-level resistance to chloramphenicol (Cm), we isolated variants that express resistance to high levels of Cm. Genetic analysis revealed that virtually all variants harboured single or multiple tandem amplifications of the respective genome segments carrying the cat insert. This process occurred independently of both the location of the cat insertion site and of the presence of a functional recA gene. Analysis of the genetically well characterised pilC region revealed a head-to-tail orientation of the amplified segments, with the junctions being located within direct repeats. Identical junctions were detected in extra-chromosomal circular DNA molecules isolated from non-selected wild-type and recA strains, suggesting that both types of structure arise by related processes. The existence of DNA circles was shown by their banding behaviour in caesium chloride/ethidium bromide density centrifugation and their resistance to digestion by exonuclease. The possible roles of such circles in processes such as pilin gene recombination, chromosomal gene amplification and genetic transformation are discussed.
Barten
R
R
Max-Planck-Institut für Biologie, Abteilung Infektionsbiologie, Tübingen, Germany.
Meyer
T F
TF
D015139:Blotting, Southern; D002499:Centrifugation, Density Gradient; D002586:Cesium / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D002712:Chlorides / Q000494:pharmacology; D004270:DNA, Circular; D004351:Drug Resistance / Q000235:genetics; D005819:Genetic Markers; D014644:Genetic Variation; D008957:Models, Genetic; D009344:Neisseria gonorrhoeae / Q000235:genetics*; D010641:Phenotype; D010957:Plasmids / Q000378:metabolism; D016133:Polymerase Chain Reaction; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D011995:Recombination, Genetic; D017422:Sequence Analysis, DNA; D020080:Tandem Repeat Sequences
D002712:Chlorides; D004270:DNA, Circular; D005819:Genetic Markers; D011500:Protein Synthesis Inhibitors; D002586:Cesium; D002701:Chloramphenicol; C028019:cesium chloride